ReviewDrugs2026

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Mariam Alamgir et al.PubMed ↗Publisher ↗

No numbers read from the abstract.